Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00240357
Other study ID # D3560L00002
Secondary ID Orbital
Status Withdrawn
Phase Phase 4
First received October 16, 2005
Last updated March 25, 2009
Start date February 2003

Study information

Verified date March 2009
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Medicines Agency
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine whether an Internet based compliance tool is superior to common diet counselling in patients with hypercholesterolemia.


Recruitment information / eligibility

Status Withdrawn
Enrollment 1175
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Available personal mailbox and access to the Internet

- Primary hypercholesterolemia with CV risk > 20% over 10 years judged by the investigator or a history of ischemic heart disease or other established atherosclerotic disease (claudicatio intermittens, apoplexia cerebri (ischaemic stroke)) or stable diabetes mellitus

- Fasting LDL-C level > 3.2 mmol/L

Exclusion Criteria:

- Known heterozygous or homozygous familial hypercholesterolemia or known type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia)

- Documented secondary hypercholesterolemia of any cause except stable diabetes mellitus (type 1 or type 2)

- History of serious adverse effect or hypersensitivity reactions to statins, in particular any history of myopathy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Lifestyle Regulation


Locations

Country Name City State
Denmark Research Site Aabenraa
Denmark Research Site Aalbaek
Denmark Research Site Aalborg
Denmark Research Site Aarhus C
Denmark Research Site Aerup
Denmark Research Site Albertslund
Denmark Research Site Ålestrup
Denmark Research Site Ans by
Denmark Research Site Bagsvaerd
Denmark Research Site Billund
Denmark Research Site Birkeroed
Denmark Research Site Broby
Denmark Research Site Broendby Strand
Denmark Research Site Broenshoej
Denmark Research Site Copenhagen V
Denmark Research Site Elsingore
Denmark Research Site Farum
Denmark Research Site Fredericia
Denmark Research Site Frederiksberg C
Denmark Research Site Frederikshavn
Denmark Research Site Frederikssund
Denmark Research Site Gentofte
Denmark Research Site Glesborg
Denmark Research Site Glostrup
Denmark Research Site Goerlev Sjaelland
Denmark Research Site Grenå
Denmark Research Site Greve
Denmark Research Site Grindsted
Denmark Research Site Haarlev
Denmark Research Site Hadsund
Denmark Research Site Haslev
Denmark Research Site Hedehusene
Denmark Research Site Hellerup
Denmark Research Site Helsinge
Denmark Research Site Herning
Denmark Research Site Hilleroed
Denmark Research Site Hoeng
Denmark Research Site Hoersholm
Denmark Research Site Holbaek
Denmark Research Site Hornbaek
Denmark Research Site Horsens
Denmark Research Site Humlebaek
Denmark Research Site Hvidovre
Denmark Research Site Ikast
Denmark Research Site Jaegerspris
Denmark Research Site Kalundborg
Denmark Research Site Karlslunde
Denmark Research Site Kastrup
Denmark Research Site Kgs. Lyngby
Denmark Research Site Kjellerup
Denmark Research Site Kokkedal
Denmark Research Site Kolding
Denmark Research Site Kvaerndrup
Denmark Research Site Langeskov, Fyn
Denmark Research Site Lyngby
Denmark Research Site Lystrup
Denmark Research Site Maeloev
Denmark Research Site Middelfart
Denmark Research Site Morud
Denmark Research Site Naerum
Denmark Research Site Naestved
Denmark Research Site Noerre Alslev
Denmark Research Site Noerresundby
Denmark Research Site Nyborg
Denmark Research Site Nykoebing F
Denmark Research Site Odense C
Denmark Research Site Odense NV
Denmark Research Site Oelstykke
Denmark Research Site Oksboel
Denmark Research Site Randers
Denmark Research Site Risskov
Denmark Research Site Roedovre
Denmark Research Site Roskilde
Denmark Research Site Roslev
Denmark Research Site Rudkoebing
Denmark Research Site Rungsted Kyst
Denmark Research Site Saeby
Denmark Research Site Sakskoebing
Denmark Research Site Saltum
Denmark Research Site Skals
Denmark Research Site Skive
Denmark Research Site Skovlunde
Denmark Research Site Slagelse
Denmark Research Site Snekkersten
Denmark Research Site Soenderborg
Denmark Research Site Soendersoe
Denmark Research Site Solroed Strand
Denmark Research Site Soroe
Denmark Research Site Stege
Denmark Research Site Stenlille
Denmark Research Site Struer
Denmark Research Site Svendborg
Denmark Research Site Svendstrup
Denmark Research Site Taastrup
Denmark Research Site Thorsoe
Denmark Research Site Toelloese
Denmark Research Site Toender
Denmark Research Site Ullerslev
Denmark Research Site Vaerloese
Denmark Research Site Vanloese
Denmark Research Site Varde
Denmark Research Site Vedbaek
Denmark Research Site Vejle
Denmark Research Site Viborg
Denmark Research Site Viby J
Denmark Research Site Vinderup
Denmark Research Site Virum
Denmark Research Site Viuf
Denmark Research Site Vojens

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary endpoint is the number and percentage of subjects from each group (rosuvastatin or rosuvastatin + a compliance enhancement tool) who reached the DSAM LDL-C target goal (LDL-C < 3.0 mmol/L) after 6 months therapy (24 weeks).
Secondary Number and percentage of subjects within the DSAM LDL-C target goal after 3 months therapy
Secondary Compliance with study drug assessed by tablet count data
Secondary Number and percentage of subjects increasing rosuvastatin dosage from 10 mg to 20 mg at week 12
Secondary Percentage change in TC, HDL-C, LDL-C, TG from week 0 to week 24
Secondary Change in weight after 6 months therapy
Secondary Change in waistline after 6 months therapy
See also
  Status Clinical Trial Phase
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Recruiting NCT03947866 - Ezetimibe-Rosuvastatin Evaluation Study
Completed NCT01709513 - Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE) Phase 3
Completed NCT01212900 - Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression Phase 4
Completed NCT00001154 - Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Completed NCT02550288 - A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383) Phase 3
Completed NCT03929198 - Translation of Pritikin Program to the Community N/A
Completed NCT04485793 - Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia N/A
Completed NCT02341924 - Validating the "Foods for Health" Portfolio of Functional Food Products N/A
Active, not recruiting NCT02223793 - Vascular Lifestyle-Intervention and Screening in Pharmacy N/A
Completed NCT01934608 - The Effect of Synching Prescription Refills on Adherence N/A
Completed NCT01941836 - Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients Phase 2
Recruiting NCT01705873 - Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen N/A
Completed NCT01670734 - Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects Phase 1
Completed NCT01678521 - Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients N/A
Completed NCT01370590 - A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) Phase 3
Completed NCT01370603 - A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1) Phase 3
Completed NCT01446679 - Special Drug Use-Results Survey of Lipitor Tablets N/A
Completed NCT01768403 - Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia N/A
Completed NCT01478789 - Efficacy of Plant Sterol-Fortified Dairy Product on Plasma Lipid and Plant Sterol Concentrations in Humans N/A